CLOMIPRAMINE HYDROCHLORIDE
Generic: CLOMIPRAMINE HYDROCHLORIDE CAPSULES
CLOMIPRAMINE HYDROCHLORIDE is FDA application ANDA209294, sponsored by LUPIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (